A detailed history of Victory Capital Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 21,294 shares of BIO stock, worth $7.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,294
Previous 21,108 0.88%
Holding current value
$7.19 Million
Previous $5.76 Million 23.59%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$263.97 - $344.64 $49,098 - $64,103
186 Added 0.88%
21,294 $7.12 Million
Q2 2024

Aug 05, 2024

BUY
$268.26 - $339.48 $884,721 - $1.12 Million
3,298 Added 18.52%
21,108 $5.76 Million
Q1 2024

May 03, 2024

BUY
$304.11 - $351.99 $42,271 - $48,926
139 Added 0.79%
17,810 $6.16 Million
Q4 2023

Feb 05, 2024

BUY
$269.37 - $365.04 $1.56 Million - $2.11 Million
5,790 Added 48.73%
17,671 $5.71 Million
Q3 2023

Nov 06, 2023

SELL
$350.25 - $422.63 $313,473 - $378,253
-895 Reduced 7.01%
11,881 $4.26 Million
Q2 2023

Jul 27, 2023

BUY
$359.49 - $486.4 $2.26 Million - $3.05 Million
6,273 Added 96.46%
12,776 $4.84 Million
Q1 2023

May 02, 2023

SELL
$418.69 - $503.0 $1.74 Million - $2.09 Million
-4,162 Reduced 39.02%
6,503 $3.12 Million
Q4 2022

Feb 10, 2023

SELL
$351.71 - $456.01 $36,226 - $46,969
-103 Reduced 0.96%
10,665 $4.49 Million
Q4 2022

Feb 09, 2023

BUY
$351.71 - $456.01 $1.02 Million - $1.32 Million
2,898 Added 36.82%
10,768 $4.53 Million
Q3 2022

Nov 02, 2022

SELL
$412.59 - $563.26 $1.83 Million - $2.5 Million
-4,438 Reduced 36.06%
7,870 $3.28 Million
Q2 2022

Aug 01, 2022

SELL
$463.67 - $597.16 $217,924 - $280,665
-470 Reduced 3.68%
12,308 $6.09 Million
Q1 2022

May 04, 2022

SELL
$524.57 - $735.42 $105,438 - $147,819
-201 Reduced 1.55%
12,778 $6.56 Million
Q4 2021

Feb 07, 2022

BUY
$708.84 - $794.68 $8,506 - $9,536
12 Added 0.09%
12,979 $9.81 Million
Q3 2021

Nov 02, 2021

SELL
$657.71 - $825.77 $388,706 - $488,030
-591 Reduced 4.36%
12,967 $9.67 Million
Q2 2021

Aug 03, 2021

SELL
$576.64 - $649.04 $2.39 Million - $2.69 Million
-4,152 Reduced 23.44%
13,558 $8.74 Million
Q1 2021

May 04, 2021

SELL
$547.01 - $662.35 $6.87 Million - $8.32 Million
-12,558 Reduced 41.49%
17,710 $10.1 Million
Q4 2020

Feb 01, 2021

SELL
$510.68 - $643.45 $403,947 - $508,968
-791 Reduced 2.55%
30,268 $17.6 Million
Q3 2020

Nov 09, 2020

BUY
$454.43 - $535.6 $7.84 Million - $9.24 Million
17,248 Added 124.89%
31,059 $16 Million
Q2 2020

Aug 07, 2020

SELL
$334.87 - $493.06 $2.35 Million - $3.45 Million
-7,006 Reduced 33.66%
13,811 $6.24 Million
Q1 2020

May 04, 2020

BUY
$320.01 - $409.07 $780,184 - $997,312
2,438 Added 13.27%
20,817 $7.3 Million
Q4 2019

Feb 06, 2020

BUY
$319.73 - $374.2 $459,132 - $537,351
1,436 Added 8.48%
18,379 $6.8 Million
Q4 2019

Feb 04, 2020

SELL
$319.73 - $374.2 $827,461 - $968,429
-2,588 Reduced 13.25%
16,943 $6.12 Million
Q3 2019

Nov 12, 2019

BUY
$304.55 - $345.24 $3.56 Million - $4.03 Million
11,676 Added 148.64%
19,531 $6.5 Million
Q2 2019

Aug 15, 2019

BUY
$286.93 - $312.59 $2.25 Million - $2.46 Million
7,855 New
7,855 $2.46 Million
Q1 2019

May 03, 2019

SELL
$224.3 - $317.41 $2.55 Million - $3.61 Million
-11,385 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$220.1 - $309.0 $11,665 - $16,377
-53 Reduced 0.46%
11,385 $2.64 Million
Q3 2018

Nov 01, 2018

BUY
$289.28 - $326.15 $924,249 - $1.04 Million
3,195 Added 38.76%
11,438 $3.58 Million
Q2 2018

Aug 02, 2018

BUY
$244.1 - $303.88 $228,721 - $284,735
937 Added 12.83%
8,243 $2.38 Million
Q1 2018

May 04, 2018

BUY
$233.97 - $274.11 $1.71 Million - $2 Million
7,306 New
7,306 $1.83 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.32B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.